Pharmacologic neuroprotection in experimental spinal cord ischemia: A systematic review

Journal of Neurosurgical Anesthesiology

Volumn 13, Issue 1, 2001, Pages 3-12

  De Haan, Peter ^a   Kalkman, Cor J ^b   Jacobs, Michael J H M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Animal models; Ischemia; Neuroprotection; Pharmacology; Spinal cord

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; 4 (2H TETRAZOL 5 YLMETHYL) 2 PIPERIDINECARBOXYLIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DEFEROXAMINE; DEXAMETHASONE; DEXTRORPHAN; DIZOCILPINE; DOXYCYCLINE; FLUOSOL DA; HALOTHANE; ISOFLURANE; LOMERIZINE; MAGNESIUM; METHOHEXITAL; METHYLPREDNISOLONE; N,N DIALLYLTYROSYLGLYCYL ALPHA (2 AMINOETHYLTHIO)HYDROCINNAMOYLLEUCINE; NALMEFENE; NALOXONE; NEUROPROTECTIVE AGENT; PENTOXIFYLLINE; PROPENTOFYLLINE; PROSTACYCLIN; PROSTAGLANDIN E1; QUADAZOCINE; SUPEROXIDE DISMUTASE; THIOPENTAL; TIRILAZAD; TISSUE FACTOR PATHWAY INHIBITOR; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; CONTROLLED STUDY; DOG; DRUG EFFICACY; EXPERIMENTAL MODEL; METHODOLOGY; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; RISK ASSESSMENT; SPINAL CORD ISCHEMIA; STATISTICAL ANALYSIS; SWINE; TEMPERATURE MEASUREMENT; TREATMENT OUTCOME;

ANIMALS; BODY TEMPERATURE; DOGS; ISCHEMIA; NEUROPROTECTIVE AGENTS; PAPIO; RABBITS; RATS; REGIONAL BLOOD FLOW; SPINAL CORD; SWINE;

EID: 0035135083     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-200101000-00002     Document Type: Article

References (114)

1. Thoracoabdominal aortic aneurysms: Preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients
2. Spinal cord monitoring: Results of the Scoliosis Research Society and the European Spinal Deformity Society Survey
3. Experience with 1509 patients undergoing thoracoabdominal aortic operations
4. Reducing postischemic paraplegia using conjugated superoxide dismutase
5. Effects of dichloroacetate in spinal stroke in the rabbit
6. Reduction of neurological damage by a peptide segment of the amyloid beta/A4 protein precursor in a rabbit spinal cord ischemia model
7. Diaspirin cross-linked hemoglobin improves neurological outcome following reversible but not irreversible CNS ischemia in rabbits
8. The AMPA antagonist LY293558 improves functional neurological outcome following reversible spinal cord ischemia in rabbits
9. Spinal cord protection during aortic occlusion: Efficacy of intrathecal tetracaine
10. The neuroprotective effects of intrathecal administration of the selective N-type calcium channel blocker ziconotide in a rat model of spinal ischemia
11. Neurological outcome correlated with spinal evoked potentials in a spinal cord ischemia model
12. Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment
13. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule
14. Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment
15. Role of free radical scavenger in protection of spinal cord during ischemia
16. Administration of bovine superoxide dismutase prevents sequelae of spinal cord ischemia in the rabbit
17. Ischemic reperfusion injury in rabbit spinal cord: Protective effect of superoxide dismutase on neurological recovery and spinal infarction
18. Amelioration of ischemic spinal cord damage by postischemic treatment with propentofylline (HWA 285)
19. KB-2796, a calcium channel blocker, ameliorates ischemic spinal cord damage in rabbits
20. Effect of propentofylline on metabolic and functional recovery in the spinal cord after ischemia
21. Comparative effects of the N-methyl-D-aspartate antagonist MK-801 and the calcium channel blocker KB-2796 on neurologic and metabolic recovery after spinal cord ischemia
22. Preventive effect of Fluosol-DA for paraplegia encountered after surgical treatment of the thoracic aorta. Preliminary results in a dog model
23. Memantine for prevention of spinal cord injury in a rabbit model
24. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia
25. Comparison of naloxone and a delta-selective antagonist in experimental spinal stroke
26. Neuropeptides in spinal cord injury: Comparative experimental models
27. Evaluation of the calcium channel antagonist nimodipine in experimental spinal cord ischemia
28. Naloxone in experimental spinal cord ischemia: Dose-response studies
29. Opiate antagonist WIN44,441-3 stereospecifically improves neurologic recovery after ischemic spinal injury
30. NMDA receptor blockade and spinal cord ischemia due to aortic crossclamping in the rat model
31. Gangliosides and spinal cord ischemia secondary to aortic cross-clamping in the rat model
32. Role of poloxamer 188 during recovery from ischemic spinal cord injury: A preliminary study
33. Selective protection of gray and white matter during spinal cord ischemic injury
34. Inhibition of neutrophil adhesion does not prevent ischemic spinal cord injury
35. Protection against post-ischemic spinal cord injury using a new 21-aminosteroid
36. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebrospinal fluid drainage
37. Acute spinal cord ischemia: Prevention of paraplegia with verapamil
38. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord
39. Does prostaglandin E1 and superoxide dismutase prevent ischaemic spinal cord injury after thoracic aortic cross-clamping?
40. Somatosensory evoked potential, a prognostic tool for the recovery of motor function following malperfusion of the spinal cord: Studies in dogs
41. Longitudinal study of cerebral spinal fluid drainage in polyethylene glycol-conjugated superoxide dismutase in paraplegia associated with thoracic aortic cross-clamping
42. Effect of mild hypothermia and the 21-aminosteroid U-74389G on neurologic and histopathologic outcome after transient spinal cord ischemia in the rabbit
43. Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine
44. The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits
45. Effects of flunarizine on neurological recovery and spinal cord blood flow in experimental spinal cord ischemia in rabbits
46. Neuronal cell death in the ischemic spinal cord: The effect of methylprednisolone
47. Effects of prostacyclin on spinal cord ischemia
48. Spinal cord protection with the use of prostacyclin during aortic occlusion
49. Protection of rat spinal cord from ischemia with dextrorphan and cycloheximide: Effects on necrosis and apoptosis
50. Spinal cord ischemia: An evaluation of pharmacologic agents in minimizing paraplegia after aortic occlusion
51. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia
52. Pharmacologic studies of the neuroprotective actions of a glutamate antagonist in ischemia
53. Fluosol and experimental spinal cord ischemia
54. Prevention of spinal cord injury after transient aortic clamping with tissue factor pathway inhibitor
55. Tissue factor pathway inhibitor protects the ischemic spinal cord
56. Riluzole prevents ischemic spinal cord injury caused by aortic crossclamping
57. Prevention of ischemic spinal cord injury following aortic cross-clamping: Use of corticosteroids
58. Insulin administration protects from paraplegia in the rat aortic occlusion model
59. The role of glucose uptake and metabolism in hyperglycemic exacerbation of neurological deficit in the paraplegic rat
60. Neurological protection by dichloroacetate depending on the severity of injury in the paraplegic rat
61. Prevention of reperfusion injury of the ischemic spinal cord: Use of recombinant superoxide dismutase
62. Antagonism of neutrophil adherence in the deteriorating stroke model in rabbits
63. Effects of calcium channel blockers on neurologic outcome after focal ischemia in rabbits
64. Treatment with conotoxin, an 'N-type' calcium channel blocker, in neuronal hypoxicischemic injury
65. Effect of protein kinase C modulation on outcome of experimental CNS ischemia
66. Efficacy of LY233053, a competitive glutamate antagonist, in experimental central nervous system ischemia
67. Delayed therapy of experimental ischemia with competitive N-methyl-D-aspartate antagonists in rabbits
68. Effect of gamma-aminobutyric acid modulation on neuronal ischemia in rabbits
69. Effects of NMDA receptor antagonists following spinal ischemia in the rabbit
70. Mild and moderate hypothermia provide better protection than a burst-suppression dose of thiopental against ischemic spinal cord injury in rabbits
71. The effects of N(G)-nitro-L-arginine-methyl ester on neurologic and histopathologic outcome after transient spinal cord ischemia in rabbits
72. Intrathecal perfusion of an oxygenated perfluorocarbon prevents paraplegia after aortic occlusion
73. Infrarenal aortic occlusion in the rabbit to assess the effect of flunarizine in the prevention of ischemic spinal cord injury
74. Paraplegia following thoracic aortic cross-clamping in dogs. No difference in neurological outcome with a barbiturate versus isoflurane
75. Neuroanesthesia adjunct therapy (mannitol and hyperventilation) is as effective as cerebrospinal fluid drainage for prevention of paraplegia after descending thoracic aortic cross-clamping in the dog
76. Protecting the ischemic spinal cord during aortic clamping. The influence of anesthetics and hypothermia
77. Thiopental modification of ischemic spinal cord injury in the dog
78. Prevention of spinal cord ischemia by selective intercostal arterial infusion of prostaglandin E1
79. Barbiturate protection in acute experimental spinal cord ischemia
80. Pharmacologic interventions for prevention of spinal cord injury caused by aortic crossclamping
81. Additive effect of allopurinol and deferoxamine in the prevention of spinal cord injury caused by aortic crossclamping
82. (-)-Deprenyl attenuates spinal motor neuron degeneration and associated locomotor deficits in rats subjected to spinal cord ischemia
83. Preliminary results of deferoxamine and L1 treatment of spinal cord ischemia
84. The effects of nimodipine on ischemic injury of the spinal cord during thoracic aortic cross-clamping
85. Protection against experimental ischemic spinal cord injury
86. Intrathecal administration of dizocilpine maleate (MK-801) attenuates ischemic damage in the rabbit spinal cord
87. Spinal cord protection with intravenous nimodipine. A functional and morphologic evaluation
88. Regional adenosine attenuates postischemic spinal cord injury
89. Intrathecal magnesium sulfate protects the spinal cord from ischemic injury during thoracic aortic cross-clamping
90. Aprotinin reduces injury of the spinal cord in transient ischemia
91. Cross-clamping of the thoracic aorta. Influence of aortic shunts, laminectomy, papaverine, calcium channel blocker, allopurinol, and super-oxide dismutase on spinal cord blood flow and paraplegia in baboons
92. Spinal cord protection by papaverine and intrathecal cooling during aortic crossclamping
93. Evaluation of pentoxifylline in experimental spinal cord ischemia
94. Spinal cord protection: Development of a paraplegia-preventive solution
95. ATP-MgCl2 utilization for spinal cord protection during experimental thoracic aortic occlusion
96. Ames Ad. Mild hypothermia and Mg++ protect against irreversible damage during CNS ischemia
97. Carbon dioxide at anesthetic levels protects against irreversible damage during spinal cord ischemia
98. The effects of moderate hypothermia and intrathecal tetracaine on glutamate concentrations of intrathecal dialysate and neurologic and histopathologic outcome in transient spinal cord ischemia in rabbits
99. Ischemia-reperfusion injury of the spinal cord: Protective effect of the hydroxyl radical scavenger dimethylthiourea
100. Medium molecular weight pentastarch reduces reperfusion injury by decreasing capillary leak in an animal model of spinal cord ischemia
101. Cerebrospinal fluid drainage and steroids provide better spinal cord protection during aortic cross-clamping than does either treatment alone
102. A multimodality approach lengthens warm ischemic time during aortic cross-clamping
103. Comparison of the neuroprotective effects of the N-methyl-D-aspartate antagonist MK-801 and the opiate-receptor antagonist nalmefene in experimental spinal cord ischemia
104. Experimental CNS ischemia: Serotonin antagonists reduce or prevent damage
105. Cyproheptadine reduces or prevents ischemic central nervous system damage
106. Phenothiazines reduce ischemic damage to the central nervous system
107. On biological assays involving quantal responses
108. The importance of brain temperature in cerebral ischemic injury
109. Temperature changes of > or = 1 degree C alter functional neurologic outcome and histopathology in a canine model of complete cerebral ischemia
110. Hypothermia but not the N-Methyl-D-Aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia
111. Effects of hyperthermia on the effectiveness of MK-801 treatment in the gerbil hippocampus following transient forebrain ischemia
112. A word of caution in interpreting the ischemic time causing apoptosis in spinal cord ischemia
113. Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis
114. Continuing postischemic neuronal death in CAl; influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats